Dual Lassa Fever and Rabies Vaccine Shows Promising Early Human Trial Results

Initial human clinical trial results for LASSARAB, an experimental vaccine targeting both Lassa fever and rabies, have been positive. Published in Nature Medicine, the study indicates the vaccine was well-tolerated by healthy adult volunteers. Furthermore, it successfully elicited strong immune responses against both viruses, suggesting potential for a combined protective measure.